Atherosclerosis and restenosis: Is there a role for RAGE?

Peter Nawroth, Angelika Bierhaus, Mario B Marrero, Hiroshi Yamamoto, David M. Stern

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by "traditional" risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.

Original languageEnglish (US)
Pages (from-to)11-16
Number of pages6
JournalCurrent Diabetes Reports
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2005

Fingerprint

Vascular Diseases
Diabetic Angiopathies
Atherosclerosis
Ligands
Pattern Recognition Receptors
S100 Proteins
Immunoglobulins
Morbidity
Mortality
Advanced Glycosylation End Product-Specific Receptor

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Nawroth, P., Bierhaus, A., Marrero, M. B., Yamamoto, H., & Stern, D. M. (2005). Atherosclerosis and restenosis: Is there a role for RAGE? Current Diabetes Reports, 5(1), 11-16. https://doi.org/10.1007/s11892-005-0061-9

Atherosclerosis and restenosis : Is there a role for RAGE? / Nawroth, Peter; Bierhaus, Angelika; Marrero, Mario B; Yamamoto, Hiroshi; Stern, David M.

In: Current Diabetes Reports, Vol. 5, No. 1, 01.01.2005, p. 11-16.

Research output: Contribution to journalReview article

Nawroth, P, Bierhaus, A, Marrero, MB, Yamamoto, H & Stern, DM 2005, 'Atherosclerosis and restenosis: Is there a role for RAGE?', Current Diabetes Reports, vol. 5, no. 1, pp. 11-16. https://doi.org/10.1007/s11892-005-0061-9
Nawroth P, Bierhaus A, Marrero MB, Yamamoto H, Stern DM. Atherosclerosis and restenosis: Is there a role for RAGE? Current Diabetes Reports. 2005 Jan 1;5(1):11-16. https://doi.org/10.1007/s11892-005-0061-9
Nawroth, Peter ; Bierhaus, Angelika ; Marrero, Mario B ; Yamamoto, Hiroshi ; Stern, David M. / Atherosclerosis and restenosis : Is there a role for RAGE?. In: Current Diabetes Reports. 2005 ; Vol. 5, No. 1. pp. 11-16.
@article{84bd4b8974a4430c9957d7ee6c72fda5,
title = "Atherosclerosis and restenosis: Is there a role for RAGE?",
abstract = "Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by {"}traditional{"} risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.",
author = "Peter Nawroth and Angelika Bierhaus and Marrero, {Mario B} and Hiroshi Yamamoto and Stern, {David M.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1007/s11892-005-0061-9",
language = "English (US)",
volume = "5",
pages = "11--16",
journal = "Current Diabetes Reports",
issn = "1534-4827",
publisher = "Current Medicine Group",
number = "1",

}

TY - JOUR

T1 - Atherosclerosis and restenosis

T2 - Is there a role for RAGE?

AU - Nawroth, Peter

AU - Bierhaus, Angelika

AU - Marrero, Mario B

AU - Yamamoto, Hiroshi

AU - Stern, David M.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by "traditional" risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.

AB - Diabetic vascular complications are a major cause of morbidity and mortality. Furthermore, such vascular disease is only incompletely explained by "traditional" risk factors in the nondiabetic complications. This situation has prompted the search for factors contributing to the pathogenesis of accelerated and more severe vascular disease in patients with diabetes. We review evidence that receptor for advanced glycation end products (RAGE), via its interaction with ligands, serves as a cofactor exacerbating diabetic vascular disease. RAGE is a member of the immunoglobulin superfamily of cell surface molecules with a diverse repertoire of ligands reminiscent of pattern recognition receptors. In the diabetic milieu, two classes of RAGE ligands, products of nonenzymatic glycoxidation and S100 proteins, appear to drive receptor-mediated cellular activation and, potentially, acceleration of vascular disease.

UR - http://www.scopus.com/inward/record.url?scp=14044268796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14044268796&partnerID=8YFLogxK

U2 - 10.1007/s11892-005-0061-9

DO - 10.1007/s11892-005-0061-9

M3 - Review article

C2 - 15663911

AN - SCOPUS:14044268796

VL - 5

SP - 11

EP - 16

JO - Current Diabetes Reports

JF - Current Diabetes Reports

SN - 1534-4827

IS - 1

ER -